Alendronate Treatment for Osteoporosis in Patients Infected with Human Immunodeficiency Virus

1. DiBisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992; 102:2108–13. 2. Miguez MJ, Lecusay R, Castillo G, Shor-Posner G. Iron overload in HIV-infected drug users with HAART treatment [abstract 623]. In: Program and abstracts of the 8th Conference on Retroviruses and Opportunistic Infections (Chicago, IL) 4–8 February 2001. Alexandria, VA; Foundation for Retrovirology and Human Health, 2001:231. 3. Sundar K, Suarez M, Banogon PE, Shapiro JM. Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: report of two patients and review of the literature. Crit Care Med 1997; 25:1425–30. 4. Brau N, Leaf HL, Wieczorek RL, Margolis DM. Severe hepatitis in three AIDS patients treated with indinavir. Lancet 1997; 349: 924–5. 5. John M, Flexman J, French MAH. Hepatitis C virus–associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease? AIDS 1998; 12:2289–93. 6. Rutschmann OT, Negro F, Hirschel B, Hadengue A, Anwar D, Perrin LH. Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J Infect Dis 1998; 177:783–5.